Percutaneous extraction of a large device-related thrombus on a Watchman™ device: a case report.

Atrial fibrillation Case report Device-related thrombus Percutaneous extraction Sentinel™ Watchman cerebral protection device device

Journal

European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 04 07 2021
revised: 03 08 2021
accepted: 13 12 2021
entrez: 20 1 2022
pubmed: 21 1 2022
medline: 21 1 2022
Statut: epublish

Résumé

Left atrial appendage occlusion devices are commonly used to prevent stroke in patients with persistent atrial fibrillation who are unable to tolerate anticoagulation. However, certain patient- and device-related characteristics increase the risk for the development of a device-related thrombus (DRT). The presence of a DRT increases the risk of stroke and should be treated. Management of DRT lacks consensus but is mostly focused on anticoagulation. In patients with large thrombi that need to be managed urgently, percutaneous extraction may be a viable option. In this report, we describe the successful management of a DRT via percutaneous thrombus extraction technology in an 81-year-old woman with a large thrombus attached to a WATCHMAN™ device. The patient initially presented with shortness of breath, and on imaging a pedunculated thrombus was detected. The thrombus was extracted using a Penumbra Lightning 12™ (Penumbra Inc., Alameda, CA, USA) catheter with a Sentinel™ (Boston Scientific, Marlborough, MA, USA) cerebral embolic protection device. The patient had no neurologic sequelae and was started on anticoagulation. Percutaneous thrombectomy can be safely performed to extract large left atrial occlusion DRT that require urgent management, without any neurologic sequelae. We believe this can be used in patients with a large DRT who would not be adequately managed with anticoagulation and in whom surgery is not feasible.

Sections du résumé

BACKGROUND BACKGROUND
Left atrial appendage occlusion devices are commonly used to prevent stroke in patients with persistent atrial fibrillation who are unable to tolerate anticoagulation. However, certain patient- and device-related characteristics increase the risk for the development of a device-related thrombus (DRT). The presence of a DRT increases the risk of stroke and should be treated. Management of DRT lacks consensus but is mostly focused on anticoagulation. In patients with large thrombi that need to be managed urgently, percutaneous extraction may be a viable option.
CASE SUMMARY METHODS
In this report, we describe the successful management of a DRT via percutaneous thrombus extraction technology in an 81-year-old woman with a large thrombus attached to a WATCHMAN™ device. The patient initially presented with shortness of breath, and on imaging a pedunculated thrombus was detected. The thrombus was extracted using a Penumbra Lightning 12™ (Penumbra Inc., Alameda, CA, USA) catheter with a Sentinel™ (Boston Scientific, Marlborough, MA, USA) cerebral embolic protection device. The patient had no neurologic sequelae and was started on anticoagulation.
DISCUSSION CONCLUSIONS
Percutaneous thrombectomy can be safely performed to extract large left atrial occlusion DRT that require urgent management, without any neurologic sequelae. We believe this can be used in patients with a large DRT who would not be adequately managed with anticoagulation and in whom surgery is not feasible.

Identifiants

pubmed: 35047747
doi: 10.1093/ehjcr/ytab517
pii: ytab517
pmc: PMC8759468
doi:

Types de publication

Case Reports

Langues

eng

Pagination

ytab517

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

J Cardiovasc Electrophysiol. 2020 Mar;31(3):718-722
pubmed: 32003095
J Am Coll Cardiol. 2021 Jul 27;78(4):297-313
pubmed: 34294267
JACC Clin Electrophysiol. 2021 Dec;7(12):1533-1543
pubmed: 34217665
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
JACC Cardiovasc Interv. 2019 Jun 10;12(11):1003-1014
pubmed: 31103540
Catheter Cardiovasc Interv. 2017 Jan;89(1):154-158
pubmed: 27762092
Circulation. 2018 Aug 28;138(9):874-885
pubmed: 29752398

Auteurs

Rhea Vyas (R)

Interventional Cardiology, Chandler Regional Medical Center, 3420 Mercy Rd, Suite 312, Gilbert, AZ 85298, USA.

Cassidy Kohler (C)

Interventional Cardiology, Chandler Regional Medical Center, 3420 Mercy Rd, Suite 312, Gilbert, AZ 85298, USA.

Ashish Pershad (A)

Interventional Cardiology, Chandler Regional Medical Center, 3420 Mercy Rd, Suite 312, Gilbert, AZ 85298, USA.

Classifications MeSH